| [1] |
SONG Cong, GAO Jinglin, BAN Feng, MENG Meng, WANG Mingxia.
Research progress of PARP inhibitors in the treatment of brain glioma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(9): 1281-1289.
|
| [2] |
WEI Xiaocheng, LI Xinrong, HE Jungang, LI Xu, QIANG Zhengze, WANG Yan, WANG Mingwei, LI Chengyi.
Research progress on antitumor effects of Hedysari radix and active components
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1112-1121.
|
| [3] |
LI Shanshan, WEI Dandan, KANG Hanyu, LIU Xiaopeng, YAN Shuxun, JIANG Shiqing.
Research progress on the clinical application and mechanism of commonly used traditional Chinese medicine in the treatment of breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 977-983.
|
| [4] |
DU Lijuan, LIN Jianhua, YE Jinghuan, SONG Lu, PENG Yanfen, LIU Yuping.
Effect and mechanism of Yiqi tongfu xiere prescription on lipopolysaccharide-induced acute lung injury in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 599-607.
|
| [5] |
XIE Jingxian, DU Jianjun, CHEN Lu, ZHANG Lijuan, YANG Yong.
Advances in pharmacokinetics of isavuconazole in special population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 709-713.
|
| [6] |
CAO Jun, ZHOU Yanlin, AI Zhengwen, LI Shigang.
Research progress on mechanism of action of Chaenomeles speciosa Nakai in the treatment of rheumatoid arthritis bone restruction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 404-411.
|
| [7] |
Celimuge, Hudeligen, XU Liang.
Network pharmacology-molecular docking analysis and experimental validation to explore the protective mechanism of Mongolian medicine Gaoyou on renal function
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 968-978.
|
| [8] |
PANG Lili, HU Ying, LUO Jie, TU Qin, CHEN Min.
Study of the mechanism of combretastatin a-4 derivative LGD5 induced G2/M cycle arrest and apoptosis in human cervical cancer HeLa cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1100-1109.
|
| [9] |
YAN Xiaoting, WANG Xinye, BAI Ming, YAO Guodong.
Research progress on anti-glioma mechanism of natural sesquiterpene lactones
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1174-1184.
|
| [10] |
XU Jinhui, YUE Hongmei, LI Yating, LIU Miaomiao, WU Xingdong, ZHU Haobin.
Advances in the study of mesenchymal stem cells in obstructive sleep apnea hypoventilation syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 114-120.
|
| [11] |
LUO Shiping, ZHANG Jie, YU Yushuai, SONG Chuangui.
Advances in targeted therapy for HER2-positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 876-886.
|
| [12] |
CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke.
Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
|
| [13] |
YANG Mengjiao, YUAN Hao, ZHENG Ya, WANG Yuping, GUO Qinghong.
Advances in the treatment of potassium-competitive acid blockers in reflux esophagitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1190-1196.
|
| [14] |
LU Ming, YIN Xiaoyu, ZHANG Zhiqing.
Research progress and mechanism of mesenchymal stem cells in the treatment of autoimmune diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 700-706.
|
| [15] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|